Providing Treatment Without Pain, Stress, or Side Effects
Yuhan Corporation announced on the 10th that it has signed a business agreement with Lisens Medical, a company specializing in rapid precision cooling technology, regarding the marketing and sales of medical devices for treating companion animal skin diseases, 'VetEase(VetEase®)' and 'VexoHeal(VexoHeal®)'.
Jo Wook-je, CEO of Yuhan Corporation (right), and Kim Gun-ho, CEO of License Medical, signed a business agreement on marketing and sales of the new medical devices for skin disease treatment, 'VetEase' and 'Vexohill,' on the 6th, and are taking a commemorative photo. Photo by Yuhan Corporation
VetEase is a new technology medical device that can be used for three different purposes with a single piece of equipment. The IN Mode is used for the application of exosomes called VexoHeal, the CX Mode can be used to relieve pain and inflammation through precision cooling anesthesia and treatment, and the FX Mode sprays ultra-low temperature carbon dioxide (CO2) gas at minus 79°C to painlessly remove benign skin tumors and other lesions.
According to the "Korea Companion Animal Report" published by the Rural Development Administration and KB Financial Group Management Research Institute, the main reasons for visiting animal hospitals are skin-related diseases such as dermatitis, eczema, and itching, and the highest costs among companion animal treatment expenses are spent on treating skin diseases.
Seongsu Kim, Executive Director of Yuhan Corporation, said, "By reducing drug dependence on steroids and other medications previously used for skin diseases that cause discomfort, minimizing side effects, and above all providing safe procedures without pain, we will offer comfort not only to companion animals but also to their owners." He added, "In particular, through the application of the exosome preparation VexoHeal, we expect various possibilities for use and high therapeutic effects."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
